Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
248,899
-
Shares change
-
+73,298
-
Total reported value, excl. options
-
$11,283,000
-
Value change
-
+$3,462,491
-
Put/Call ratio
-
240%
-
Number of buys
-
11
-
Number of sells
-
-3
-
Price
-
$45.37
Significant Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q2 2018
27 filings reported holding CURE - DIREXION SHS ETF TR - HEALTHCARE BUL as of Q2 2018.
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 248,899 shares
.
Largest 10 shareholders include CITADEL ADVISORS LLC (78,471 shares), Tower Research Capital LLC (TRC) (55,597 shares), Virtu Financial LLC (27,106 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (26,816 shares), JANE STREET GROUP, LLC (21,346 shares), BANQUE PICTET & CIE SA (10,120 shares), Traynor Capital Management, Inc. (7,481 shares), Capital Analysts, LLC (6,000 shares), WOLVERINE TRADING, LLC (4,769 shares), and UBS Group AG (3,722 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.